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Acute respiratory health effects of air pollution on children
with asthma in US inner cities
George T. O’Connor, MD, MS,a Lucas Neas, DSc,b Benjamin Vaughn, MS,c Meyer Kattan, MD,d Herman Mitchell, PhD,b
Ellen F. Crain, MD,e Richard Evans III, MD,f Rebecca Gruchalla, MD, PhD,g Wayne Morgan, MD,h James Stout, MD,i
G. Kenneth Adams, MD,j* and Morton Lippmann, PhDk Boston, Mass, Research Triangle Park and Chapel Hill, NC, New York,
Bronx, and Tuxedo, NY, Chicago, Ill, Dallas, Tex, Tucson, Ariz, Seattle, Wash, and Bethesda, Md
Background: Children with asthma in inner-city communities
may be particularly vulnerable to adverse effects of air
pollution because of their airways disease and exposure to
relatively high levels of motor vehicle emissions.
Objective: To investigate the association between fluctuations in
outdoor air pollution and asthma morbidity among inner-city
children with asthma.
Methods: We analyzed data from 861 children with persistent
asthma in 7 US urban communities who performed 2-week
periods of twice-daily pulmonary function testing every 6
months for 2 years. Asthma symptom data were collected every
2 months. Daily pollution measurements were obtained from the
Aerometric Information Retrieval System. The relationship of
lung function and symptoms to fluctuations in pollutant
concentrations was examined by using mixed models.
Results: Almost all pollutant concentrations measured were
below the National Ambient Air Quality Standards. In single-
pollutant models, higher 5-day average concentrations of NO2,
sulfur dioxide, and particles smaller than 2.5 mm were
associated with significantly lower pulmonary function. Higher
pollutant levels were independently associated with reduced
lung function in a 3-pollutant model. Higher concentrations of
NO2 and particles smaller than 2.5 mm were associated with
asthma-related missed school days, and higher NO2
concentrations were associated with asthma symptoms.
Conclusion: Among inner-city children with asthma, short-term
increases in air pollutant concentrations below the National
Ambient Air Quality Standards were associated with adverse
respiratory health effects. The associations with NO2 suggest
that motor vehicle emissions may be causing excess morbidity in
this population. (J Allergy Clin Immunol 2008;121:1133-9.)
Key words: Nitrogen dioxide, ozone, sulfur dioxide, carbon monox-
ide, fine particle emissions, asthma in children
The short-term respiratory health effects of outdoor air pollu-
tants at levels currently found in the United States remain
uncertain. Time-series analyses have revealed increased cardio-
pulmonary mortality and hospitalizations after days with elevated
particulate matter (PM) air pollution,1-4 as well as increased
asthma-related emergency visits and hospitalizations after days
with high pollution levels.5-7 Some authors, however, have
stressed the importance of confirming the results of ecologic anal-
yses with studies using individual-level data.8
Panel studies of healthy children 9-11 or childrenwith asthma12-19
have revealed short-term increases in respiratory symptoms andde-
creases in lung function after exposure tohigher levels ofPM20 and/
or O3. Most studies have been limited to fairly small samples of
subjects and a single-season. Few published panel studies10,14,21-
24 have examined the effects of PM with aerodynamic diameter
less than 2.5mm (PM2.5), a pollutant that penetrates to distal bron-
chioles and is strongly associatedwithmortality in population stud-
ies.1,2,4,25 Studies on relatively small numbers of patients with
asthma have suggested an adverse effect of PM2.5 on peak expira-
tory flow rate (PEFR) and symptoms.19 A panel study of 58 chil-
dren with asthma in Seattle revealed that increases in PM2.5 and
PM with aerodynamic diameter less than 10 mm (PM10), as well
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PEFR: Peak expiratory flow rate
PM: Particulate matter
PM10: Particulate matter with aerodynamic diameter of less
than 10 mm
PM2.5: Particulate matter with aerodynamic diameter of less
than 2.5 mm
as increases in CO, a surrogate for motor vehicle emissions, were
associated with an increased risk of severe asthma attacks and
medication use.26
Children with asthma living in poor urban neighborhoods are
particularly vulnerable to the adverse effects of air pollution
because of their underlying airways disease and their residence in
communities with relatively high levels of motor vehicle emis-
sions.27 Previous panel studies focusing on urban children with
asthma19,21,28 have suggested effects of air pollution on symp-
toms, but effects on PEFR have not been consistent, and previous
studies did not include measurements of FEV1. The substantial
economic implications of compliance with ambient air quality
standards require more precise estimates of the health effects of
air pollution in this population.
The Inner-City Asthma Study (ICAS)29,30 evaluated the effec-
tiveness of amultifaceted, home-based, environmental intervention
for inner-city children with asthma. Using data collected for this
study,we analyzed the relationship between short-termfluctuations
in outdoor air pollutant concentrations and changes in pulmonary
function and respiratory symptoms among children with asthma
in 7 US inner-city communities. Although the respiratory health
of children with asthma may be affected by outdoor pollution,
indoor pollution, and indoor exposure to pollution from outdoor
sources, this study focuses on ambient pollution concentrations as
measured outdoors, currently the only pollution concentrations reg-
ulatedby federal law.ThedatawerecollectedbetweenAugust 1998
and July 2001, reflecting current ambient pollutant concentrations.
METHODS
Additional detail on methods is provided in this article’s Online Repository
at www.jacionline.org.
Sample
The ICAS cohort included 937 childrenwith persistent asthma and atopy (1
or more positive allergy skin tests to common indoor allergens) who were 5 to
12 years old and lived in low-income census tracts in Boston, the Bronx,
Chicago, Dallas, New York, Seattle, and Tucson. Subject recruitment took
place throughout a full 12-month period, such that the monitoring of health
and pollution data, as described, was staggered throughout the calendar year.
We excluded 53 children living in the Tacoma area near Seattle because of a
lack of nearby pollution monitoring stations with sufficient data and 23
children from other sites who had insufficient pulmonary function data,
leaving 861 children for analysis.
Health data
Every 6 months for 2 years, children performed twice-daily spirometry for
2 weeks by using an electronic spirometer that recorded the date and time of
measurements. Percent predicted values were calculated by using published
regression equations.31 Asthma symptom data were collected by telephone in-
terview every 2 months. Caretakers were asked to recall the number of days in
the past 2 weeks that the child experienced specific asthma symptoms or
missed school because of asthma.
Pollution measurements
Daily measurements of the outdoor concentrations of PM2.5, NO2, SO2,
CO, and O3 (average of hourly measurements) were obtained from the US En-
vironmental Protection Agency Aerometric Information Retrieval System da-
tabase.32 Within each community, we used data from all available monitoring
sites that were located in reasonable proximity to the homes of the study pop-
ulation, that had reasonably complete pollution data during the study period,
and that were not located at an industrial pollution source that would make
measurements meaningless in terms of community exposure. In most cases,
subjects’ homes were fairly tightly clustered; the median distance to the near-
est monitoring station was 2.3 km. For each monitoring site, we used all avail-
able pollution data; if more than 1 monitoring site within a city was used, their
readings were combined using the method of Zanobetti et al.33
Data analysis
The relationships between lung function and pollutant concentrations were
assessed by using mixed-effects models, in which each day’s FEV1 or PEFR
(percentage of predicted) was the dependent variable, and the independent
variables included pollutant concentrations (the mean of the 1 or more days
preceding the day of the pulmonary function measurement), city, month, a
city-by-month interaction term, the mean temperature on the day of the pul-
monary function measurement, whether it was obtained in the morning or
evening, and the ICAS intervention group. This mixed modeling approach as-
sesses variation of health outcomes with pollution level both within individ-
uals and between individuals. The models let individuals have their own
individual intercept of the outcome-exposure relationship, thereby adjusting
for differences in the baseline lung function of individuals. Similar to other
time-series investigations of acute air pollution health effects, we examined
alternative pollution concentration moving averages from 1 to 7 days. The
5-day moving average pollution concentration provided the most consistent
significant associations with lung function effects, and we therefore used 5-
day averages for the main analyses presented.
Single-pollutant models were used to examine the relationship of lung
function to 1 pollutant at a time. A 3-pollutant model including NO2, O3, and
PM2.5 was used to evaluate the independent relationship of lung function to
the concentration of each of these pollutants while adjusting for the associa-
tions with the other 2 pollutants.
The relationship of 2-week recall symptoms to pollutant measurements
were assessed by using generalized estimating equation models. The fre-
quency of each symptom or the occurrence of 1 or more school absence during
the recall period was the dependent variable, and the independent pollution
variable was the mean concentration during the 19 days preceding the
interview—that is, the 14 days of the symptom recall period plus a 5-day lag
period preceding the symptom recall period. The other independent variables
were the same as in the lung function models.
For all models, results are presented by contrasting symptoms or lung
function at the 90th percentile of all measurements of a given pollutant to
symptoms or lung function at the 10th percentile of measurements.
RESULTS
The 861 children had a mean age of 7.7 years and were mostly
black or Hispanic (Table I). At entry, only 11.5 % were taking in-
haled corticosteroids, and nearly half lived with a cigarette
smoker. We retrieved 3299 two-week periods of pulmonary func-
tion data from the 861 children—that is, 70.4% of the maximum
possible—and 10,056 telephone interviews—that is, 89.4% of the
maximum possible.
Across all communities, there were 5053 observation days
with data for all 5 pollutants. There was a substantial correlation,
after adjustment for community and month, among the daily
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concentrations, with only PM2.5 and O3 uncorrelated (Table II).
PM2.5 and SO2 concentrations were well below the 24-hour aver-
age National Ambient Air Quality Standards (NAAQS), and 24-
hour NO2 concentrations were below the annual NAAQS (Fig
1). Maximum 8-hour average CO concentrations were well below
the NAAQS, and only 1% to 2% of the maximum 8-hour average
O3 concentrations exceeded the NAAQS, which allows 3 exceed-
ances per year.
In single-pollutant models, the FEV1 and PEFR were signifi-
cantly related to the 5-day average PM2.5, SO2, and NO2, but
not to the 1-day average concentration (Fig 2). For O3, effect es-
timates from models with 1-day or 5-day average concentrations
did not differ. For PM2.5, SO2, and NO2, 5-day average concen-
trations at the 90th percentile were associated with significantly
lower FEV1 and PEFR compared with concentrations at the
10th percentile (Table III). For O3 and CO, associations with
FEV1 and PEFR were smaller and not statistically significant.
For each pollutant, we also created models to examine whether
the 5-day average pollutant concentration was related to the risk
of experiencing a percent-predicted FEV1 and PEFR more than
10% below personal best (defined as the 95th percentile of all
FEV1 or PEFR measurements for that individual). The risk of a
experiencing a percent-predicted FEV1 more than 10% below
personal best was significantly related to the 5-day average con-
centrations of NO2 (odds ratio associated with an increment
from the 10th to the 90th percentile of pollutant concentration,
1.17; 95% CI, 1.01, 1.37) and PM2.5 (odds ratio, 1.14; 95% CI,
1.01, 1.29). The risk of a experiencing a percent-predicted
PEFR more than 10% below personal best was significantly re-
lated to 5-day average NO2 (odds ratio, 1.23; 95% CI, 1.05,
1.44), PM2.5 (odds ratio, 1.18; 95% CI, 1.03, 1.35), and SO2
(odds ratio, 1.32; 95% CI, 1.02, 1.73).
In the 3-pollutant model including NO2, O3, and PM2.5 as pre-
dictors of FEV1, higher 5-day average NO2 and PM2.5 concentra-
tions were independently associated with significantly lower
in FEV1 (Table III). An association between O3 and FEV1 was
of similar magnitude but not statistically significant. In the
3-pollutant model for PEFR, higher 5-day average NO2 and O3
concentrations were independently associated with significantly
lower PEFR (Table III). Lung function models including all 5
pollutants revealed, as expected, that relationships to individual
pollutants were diluted compared with those seen in 3-pollutant
models; however, NO2 remained a significant predictor of
FEV1, and NO2 and O3 remained significant predictors of PEFR
in these 5-pollutant models (results not shown).
For asthma-related symptoms and school absences during the
2-week recall periods, single-pollutant models revealed signifi-
cant or nearly significant positive associations between higher
NO2 concentrations and each of the health outcomes (Table IV).
Significant positive associations with symptoms but not school
absence were observed in the single-pollutant model for CO.
The O3, PM2.5, and SO2 concentration did not appear signifi-
cantly associated with symptoms or school absence except for a
significant association between PM2.5 and school absence. In
the 3-pollutant model that included NO2, O3, and PM2.5 (Table
IV), the NO2 concentration remained significantly or nearly sig-
nificantly associated with each of the symptoms, although the as-
sociation with missed school days was attenuated and no longer
statistically significant. The O3 and PM2.5 concentrations were
not significantly associated with symptoms or school absences
in the 3-pollutant models. In symptommodels including all 5 pol-
lutants, the associations for NO2 were slightly attenuated and no
longer statistically significant, with the associations divided
between NO2 and CO terms in the model (results not shown).
We performed analyses in which interaction terms were added
tomodels to look for potential modification of air pollution effects
by various subject characteristics. These analyses revealed no
consistent pattern of effect modification by the use of inhaled
corticosteroid, the presence of a cigarette smoker in the home,
more severe asthma (defined by a composite index based on use of
inhaled corticosteroid, symptom frequency in the past 2 weeks,
and unscheduled health care utilization in the past 2 months), or
ICAS study group (intervention versus control).
DISCUSSION
We observed significant associations between pollutant expo-
sures and respiratory health outcomes in a large sample of
children with asthma in 7 urban US communities, despite the fact
that the daily pollutant concentrations were almost all below the
current NAAQS. Higher concentrations of NO2, PM2.5, and SO2
were associated with decrements in pulmonary function, and
higher NO2 concentrations were also associated with more fre-
quent asthma symptoms and asthma-related school absences.
We observed associations between 5-day average pollutant con-
centrations and lung function decrements that were not seen for
single-day average concentrations, suggesting that some of the
TABLE I. Characteristics of 861 children with asthma included in
the analysis
Characteristic
Mean (SD) or
percentage
Age (y) 7.67 (2.00)
Male sex 62.1%
Race/ethnicity
Black 39.7%
Hispanic 42.9%
Non-Hispanic white 5.7%
Other 11.7%
Using inhaled corticosteroid on study entry 11.5%
One or more cigarette smokers at home 47.4%
Low birth weight 12.8%
Baseline % predicted premed FEV1 85.5 (22.4)
Baseline % predicted premed PEF 73.5 (21.9)
Morbidity outcomes over a period of
2 years of follow-up
Mean symptom days
per 2 weeks (SD)
Days with wheeze, tightness in chest, cough 2.9 (3.75)
Nights child woke up because of asthma 1.7 (2.76)
Days child slowed down or stopped play 2.2 (3.20)
No. of school days missed 0.8 (1.62)
TABLE II. Correlations between daily pollutant concentrations,
adjusted for community and month
Pollutant PM2.5 Ozone NO2 CO SO2
PM2.5 1.00 20.02 0.59 0.44 0.37
Ozone 1.00 20.31 20.38 20.43
NO2 1.00 0.54 0.59
CO 1.00 0.32
SO2 1.00
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effects of inhaled pollutants on the lower airways require expo-
sure longer than a single day.
Previous studies of the effects of air pollution on the health of
inner-city children with asthma revealed associations of some
pollutants with respiratory symptoms but less consistent associ-
ations with lung function. A panel study of 846 urban children
with asthma in the Northeast and Midwest United States19 re-
vealed that the morning PEFR was reduced and symptoms were
increased in association with increased O3, but PEFR was not re-
lated to SO2 or NO2. In a panel study of 71 childrenwith asthma in
Mexico City, where ambient levels of PM10 and O3 exceeded
those in our study, PEFR and respiratory symptoms were associ-
ated with the concentrations of both pollutants.21 Among 22 His-
panic children with asthma in Los Angeles, the concentrations of
O3, NO2, SO2, and PM10 were associated with symptoms but not
with reductions in PEFR.28 Our study differs from previous stud-
ies in its use of year-round data on a large number of patients with
asthma followed for 2 years; the availability of data on PM2.5 and
4 other criteria pollutants; and the measurement of daily FEV1,
which is more sensitive to mild airflow limitation than PEFR.
We observed stronger associations between decrements in lung
function and increments in NO2 and SO2, but aweaker association
with O3 than in 1 previous study.
19 We also observed a significant
association between decrements in lung function and increments
in PM2.5, which was not measured in the other studies of inner-
city children with asthma.
Our observation of greater associations of lung function with
5-day average than with 1-day average pollutant concentrations
is consistent with previous reports. For example, a time-series
study in the Atlanta area revealed that the association between
air quality measurements and ambulatory visits related to
pediatric asthma was strongest for the 3-day to 5-day lagged
moving average air quality measurements.34 An earlier time-
series study in Utah Valley also found that using 5-day average
pollution measurements led to the strongest associations of
particulate air pollution levels with respiratory symptoms in
children.35
Some previous panel studies not focused on inner-city patients
with asthma have evaluated the associations between ambient air
PM2.5 and lung function and respiratory symptoms among
FIG 2. Estimated effect (95% CI) on pulmonary function of a 10th to 90th percentile increment in pollutant
level in single-pollutant models among 937 inner-city children with asthma. The estimates shown are from
models that included either a 1-day or 5-day average of pollutant concentration as the independent expo-
sure variable. Adjusted for site, month, site-by-month interaction, temperature, and intervention group in
mixed models. A, Percent predicted FEV1 as outcome variable. B, Percent predicted PEFR as outcome
variable.
FIG 1. Box plots showing the distribution of the ambient air pollutant concentrations measured in all 7
communities during the 2-year period of the study. The bars indicate the 1st, 10th, 25th, 50th, 75th, 90th, and
99th percentiles of the measurements recorded. The red horizontal line near the top of some plots indicates
the NAAQS for that pollution measure. Avg, Average; Max, maximum.
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childrenwith andwithout asthma.10,14,21-24 A systematic review20
calculated a pooled effect estimate based on 5 studies of the asso-
ciation between changes in PM2.5 and PEFR. This estimate
ranged from 23.15 to 27.20 L/min change in PEFR per 50 ug/
m3 change in PM2.5, depending on the calculation method. Our
estimate of a 1.1% predicted decrease in PEFR per 13.2 ug/m3 in-
crease in PM2.5 equals a212.5 L/min change in PEFR per 50 ug/
m3 change in PM2.5, assuming a predicted value for PEFR of 300
L/min (approximate average for our sample at themidpoint of fol-
low-up). Our larger effect estimate may reflect the susceptibility
of our patients with persistent asthma and their inner-city settings,
where motor vehicle exhaust may make a larger contribution to
PM2.5 than in other locations.27
A previous study of children with asthma in Southern
California36 found that bronchitis symptoms were more closely
associated with NO2 and particulate organic carbon, with both
surrogates for motor vehicle exhaust, than with the other mea-
sured pollutants. Venn et al37 linked childhood wheezing to resi-
dence near a main road, and Hoek et al38 and Laden et al39 have
associated excess mortality more closely with exposure to traffic-
related pollutants than to pollutants from other sources. Peters
et al40 and Pekkanen et al13 linked ultrafine particles (diameters
below 0.1 um) to respiratory symptoms. Those findings suggest
that ambient air pollution derived from motor vehicle emissions
may have injurious effects on the respiratory health of children
with asthma, and that the active agents could include specific or-
ganics and/or the ultrafine particles that are emitted from internal
combustion engines. In the absence of data on the composition of
particles in the PM2.5 fraction, which varies with geographic re-
gion and season, we cannot determinewith certainty the source of
fine particles associated with pulmonary function decline in our
study.
Although we observed associations between pollutant concen-
trations and respiratory health in single-pollutant and multi-
pollutant models, causal inferences regarding individual
pollutants are limited by 2 factors. First, there are significant
intercorrelations among the levels of most of the pollutants
examined. Second, a particular pollutant concentration may serve
as a surrogate measure of other, unmeasured, and possibly more
causal components of urban air pollution mixtures. For example,
Sarnat et al41 reported that, in Baltimore, Md, the ambient con-
centrations of the gaseous criteria pollutants were unrelated to
personal exposures but were significantly related to personal ex-
posure to PM2.5, which, in inner cities, is the most spatially
TABLE III. Mean (95% CI) change in pulmonary function parameter at the 90th percentile of pollutant concentration relative to the
10th percentile
10th to 90th percentile
change
Estimated change in FEV1, %
predicted
Estimated change in PEFR, %
predicted
Single-pollutant models
O3 26.7 ppb 20.55 (21.38, 10.27) 20.29 (21.15, 10.57)
PM2.5 13.2 mg/m3 21.47 (22.00, 20.94) 21.10 (21.65, 20.56)
SO2 12.4 ppb 21.60 (22.54, 20.67) 22.14 (23.08, 21.19)
NO2 20.4 ppb 21.36 (21.92, 20.80) 21.66 (22.24, 21.08)
CO 872.1 ppb 20.56 (21.31, 10.20) 20.49 (21.24, 10.27)
Three-pollutant model
O3 26.7 ppb 20.72 (21.70, 10.26) 21.48 (22.50, 20.45)
PM2.5 13.2 mg/m3 20.73 (21.33, 20.12)* 20.25 (20.88, 10.38)
NO2 20.4 ppb 21.09 (21.77, 20.41) 21.61 (22.32, 20.90)
Adjusted for site, month, site-by-month interaction, temperature, and intervention group in a mixed model. Independent variable is 5-day average pollutant concentration.
*Significant at P < .05.
significant at P < .01.
TABLE IV. Risk of asthma-related symptoms and missed school days at the 90th percentile of pollutant concentration relative
to the 10th percentile
Wheeze-cough,
days/2 wk
Nighttime asthma,
nights/2 wk
Slow play,
days/2 wk
Missed school, $1
vs 0 d/2 wk
10th to 90th percentile change Pollution impact (95% CI)z Odds ratio (95% CI)
Single-pollutant models
O3 26.7 ppb 1.03 (0.82, 1.28) 0.85 (0.64, 1.14) 0.87 (0.67, 1.14) 1.31 (0.83, 2.06)
PM2.5 13.2 mg/m3 0.98 (0.88, 1.09) 1.11 (0.94, 1.30) 1.01 (0.89, 1.15) 1.33 (1.06, 1.66)*
SO2 12.4 ppb 1.06 (0.87, 1.30) 1.14 (0.89, 1.45) 1.07 (0.85, 1.35) 1.13 (0.78, 1.64)
NO2 20.4 ppb 1.17 (0.99, 1.39) 1.37 (1.08, 1.73) 1.26 (1.04, 1.54)* 1.67 (1.18, 2.36)
CO 872.1 ppb 1.26 (1.03, 1.55)* 1.35 (1.07, 1.71)* 1.28 (1.04, 1.59)* 1.08 (0.76, 1.53)
Three-pollutant model
O3 26.7 ppb 1.04 (0.82, 1.32) 0.82 (0.60, 1.12) 0.86 (0.65, 1.14) 1.35 (0.82, 2.20)
PM2.5 13.2 mg/m3 0.92 (0.81, 1.05) 1.03 (0.86, 1.23) 0.92 (0.79, 1.06) 1.13 (0.87, 1.45)
NO2 20.4 ppb 1.24 (1.02, 1.52)* 1.29 (1.00, 1.68) 1.33 (1.06, 1.66)* 1.33 (0.87, 2.02)
*Significant at P < .05.
Significant at P < .01.
Numbers given are coefficients from the negative binomial model and indicate the multiplicative effect per unit change. For example, 1.17 indicates that a pollution increase from
the 10th to 90th percentile of the distribution would result in a 17% increase in symptom frequency. Covariates include site, month, site-by-month interaction, temperature, call
number, and intervention group. Independent variable is the 19-day average pollutant concentration.
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homogeneous of these monitored pollutants. Despite these limita-
tions, the observed associations with NO2, which is derived
mostly from motor vehicle exhaust, suggest that traffic-derived
pollution was responsible for at least part of the observed associ-
ations between pollutant concentrations and health effects. Stud-
ies of indoor NO2 exposure derived from cooking and heating
sources indicate that such exposure may worsen respiratory
symptoms in children with asthma.42 A time-series study in Aus-
tralia and NewZealand7 revealed that the outdoor NO2 concentra-
tion was associated with asthma hospitalizations, whereas other
pollutants were not. Thus, outdoor NO2 exposure may adversely
affect the health of children with asthma, although the NO2 con-
centration may simply be acting as a surrogate for 1 or more other
components of motor vehicle emissions.
Our data demonstrate temporal associations of air pollution
levels with lung function and, for NO2, asthma symptoms. A 3-
pollutant model estimates that an increase in NO2 of 20.4 ppb
was associated with a relative risk of days with wheeze or cough
of 1.24—that is, a 24% increase in the frequency of symptom
days. This same increase in NO2 was associated in a 3-pollutant
model with an average reduction in FEV1 of 1.09% of the pre-
dicted level. Although our study lacked statistical power to detect
excess hospitalizations or emergency visits in relation to air pol-
lution, many asthma-related school absences were reported. A
20.4-ppb increase in NO2 was associated with a 67% increase
in the risk of asthma-related school absence in a single-pollutant
model. In 3-pollutant models, the excess risk of school absence
appeared to be partitioned among multiple pollutants and did
not reach statistical significance for any single pollutant. These
associations may reflect irritant-induced bronchial smooth mus-
cle constriction and/or mucosal inflammation, alterations with
the potential for chronic as well as acute health effects. In a cohort
of children in Southern California,43 lung function growth over a
period of 8 years was significantly reduced in relation to average
exposure to NO2 and PM2.5. If the associations with lung func-
tion, symptoms, and school absences observed in our study reflect
airway effects with the potential to influence growth, then these
acute manifestations of asthma morbidity could be associated
with long-term adverse consequences of pollution exposure.
Passive smoke exposure (48% of homes) and inhaled cortico-
steroid use (12% of subjects) are not likely to be related to daily
outdoor pollution fluctuations and therefore would not be ex-
pected to confound the associations between outdoor pollutant
concentrations and asthma morbidity. These exposures, however,
have important effects on the bronchial mucosa and could
potentiallymodify the respiratory effects of pollutants.We looked
for, but observed no evidence of, such effect modification,
although our power to detect such modification may have been
limited, especially for inhaled corticosteroid use.
Strengths of our study include its large sample of children with
asthma with 2 years of individual-level data, including FEV1, and
the availability of PM2.5 data. The absence of personal and in-
door air-pollutant exposure data may be interpreted as a limitation
because it introduces additional exposure misclassification that
would tend to reduce the effect estimates. However, the central-
site, outdoor air quality measurements used in this study reflect
the current approach to the regulation of air pollution, and the
health effects associated with these measurements are therefore
of substantial public health importance. Furthermore, the outdoor
concentrations of the criteria pollutants, especially PM2.5, are
reasonably homogeneous within a given city on a given day.44
In addition, in the homes of our subjects, indoor levels of NO2
are significantly correlated with outdoor levels measured at cen-
tral monitoring sites (data not shown), especially during months
when windows are open. To the extent that exposure misclassifi-
cation does occur as a result of reliance on central pollution mon-
itors, such misclassification would bias associations to the null.
Another potential limitation is that half of the children in our sam-
ple were included in a home-based environmental intervention,
potentially altering responses to air pollution. Our models in-
cluded adjustment for intervention group. It remains possible
that the bedroom high-efficiency particle air filters provided to
most intervention group children could have diminished to
some degree the influence of airborne fine particles in this half
of the sample; however, we observed no significant modification
of associations by intervention group.
In conclusion, we observed associations between short-term
increases in air pollutant concentrations and health outcomes
including reduced pulmonary function, respiratory symptoms,
and missed school days related to asthma among urban children
with moderate-to-severe asthma. Although the observed associ-
ations cannot be attributed with certainty to individual pollutants,
the associations with NO2 suggest that 1 or more components of
motor vehicle emissions may be causing excess respiratory symp-
toms among this vulnerable population of children with asthma,
and that air pollutant levels below the current NAAQS may cause
adverse effects on the health of children with asthma. Given the
high prevalence of asthma in urban communities, these findings
have important implications for air quality regulation and urban
transportation policy.
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Clinical implications: Efforts to reduce air pollution in US cities
are warranted to protect the health of children with asthma.
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METHODS
Sample
In conjunction with ICAS,E1,E2 we conducted an observational panel study
of the respiratory health effects of air pollution. The objective of ICAS was to
determine whether a home-based environmental intervention tailored to each
child’s sensitization and environmental risk profile could reduce the symptoms
of asthma and decrease the use of health care services. Simultaneously, using a
2-by-2 factorial design, ICAS evaluated a physician-feedback intervention
that included bimonthly reports of the children’s asthma symptoms and use
of health care services to their primary care physicians.E3 The ICAS cohort in-
cluded 937 children with persistent asthma. They were 5 to 12 years old, had a
positive allergy skin test result to at least 1 indoor allergen, lived in low-in-
come census tracts in Boston, the Bronx, Chicago, Dallas, New York, Seattle,
and Tucson, and were followed for 24 months as part of the ICAS protocol.
Subject recruitment took place throughout a full 12-month period, such that
the monitoring of health and pollution data, as described, was staggered
throughout the calendar year. For the current study, we excluded from the Se-
attle area cohort 53 children that lived in Tacoma because of a lack of nearby
US Environmental Protection Agency monitoring stations with sufficiently
complete data collection. Of the remaining 884 children, 23 from other sites
were excluded because of insufficient pulmonary function data, and 861 chil-
dren were included in the analysis.
Health data
Every 6 months, children performed twice-daily measurements of PEFR
and FEV1 for 2 weeks using an electronic spirometer that recorded the date
and time of each measurement. At the beginning of each 2-week period, chil-
dren were instructed how to perform spirometry and were asked to perform 14
consecutive days of morning and evening forced expiratory maneuvers. The
electronic spirometer coached the subjects through 3 maneuvers in the morn-
ing and again in the evening, then stored the highest FEV1 and the highest PEF
from these 3 maneuvers. From the recorded data, percent predicted values
were calculated by using published regression equationsE4 that include param-
eters for race and ethnicity (black, white, Hispanic), sex, and height.
Caretaker-reported asthma symptom data were collected by telephone
interviews every 2 months for the full 2-year follow-up period. In each
telephone interview, caretakers were asked to recall the number of days in the
past 2 weeks that the child experienced wheezing or coughing, was awakened
at night by asthma symptoms, experienced slower than normal play or activity
because of asthma symptoms, and missed school because of asthma symp-
toms. The specific days on which symptoms had occurred were not queried.
Pollution measurements
Dailymeasurements of the ambient air concentrations of PM2.5, NO2, SO2,
CO, andO3 (average of hourlymeasurements), were obtained from theUSEn-
vironmental Protection Agency Aerometric Information Retrieval System da-
tabase.E5 Within each community, we used data from all available monitoring
sites that were located in reasonable proximity to the homes of the study pop-
ulation, that had reasonably complete pollution data during the study period,
and that were not located at an industrial pollution source that would make
measurements meaningless in terms of community exposure. In most cases,
subjects’ homes were fairly tightly clustered; the median distance to the near-
est monitoring station was 2.3 km. For each monitoring site, we used all avail-
able pollution data; if more than 1 monitoring site within a city was used, their
readings were combined using the method of Zanobetti et al.E6
Data analysis
The relationships between FEV1 and PEFR and the pollutant concentra-
tions were assessed by using mixed-effects models, in which each day’s
FEV1 or PEFR, expressed as a percentage of predicted, was used as the depen-
dent variable, and the independent variables included pollutant concentrations
(the mean of the 1 or more days preceding the day of the pulmonary function
measurement), city, month (to adjust for seasonal effects), a city-by-month in-
teraction term, a piecewise linear spline for themean temperature on the day of
the pulmonary function measurement (knot points at 42.78F and 72.68F),
whether it was obtained in the morning or evening, and the ICAS intervention
group. This mixed modeling approach assesses variation of health outcomes
with pollution level both within individuals and between individuals. The
models let individuals have their own individual intercept of the outcome-ex-
posure relationship, thereby adjusting for differences in the baseline lung
function of individuals. Similar to other time-series investigations of the acute
effects of air pollution on respiratory health, we examined alternative pollu-
tion concentration moving averages from 1 to 7 days as well as undistributed
lag models. We observed that a 5-day moving average pollution concentration
provided the most consistent significant associations with lung function ef-
fects, and we therefore used 5-day averages for the main analyses presented.
To be included in the analysis, lung function measurements on a given day
needed to be associated with nonmissing pollution data on at least 4 of the pre-
vious 5 days. When pollution data were missing for 1 of the 5 days, the 4-day
average was used in place of the 5-day average.
Single-pollutant models were used to examine the relationship of lung
function to 1 pollutant at a time. A 3-pollutant model including NO2, O3, and
PM2.5 was used to evaluate the independent relationship of lung function to
the concentration of each of these pollutants while adjusting for the associa-
tions with the other 2 pollutants. We chose these 3 pollutants for the multipol-
lutant model because of their known health effects and because the daily O3
and PM2.5 concentrations are not correlated in the exposure data used in
this study (as described in Results).
The relationships of 2-week recall symptoms to pollutant measurements
were assessed by using generalized estimating equation models, with a
negative binomial distribution for count outcomes and a binomial distribution
for the occurrence of 1 or more asthma-related school absence. The frequency
of each symptom or the occurrence of 1 or more school absence during the 2-
week recall period was the dependent variable, and the independent pollution
variable was the mean concentration during the 19 days preceding the
interview—that is, the 14 days of the symptom recall period plus a 5-day lag
period preceding the symptom recall period. We chose this approach because
of the finding that a 5-day moving average revealed the most consistent
associations between pollution concentrations and lung function (as noted),
suggesting that respiratory effects may be influenced by cumulative exposure
over multiple days. The other independent variables were the same as in the
lung function models. The effect estimates from the models for both
pulmonary function and symptoms were scaled to a 10th to 90th percentile
increase of the daily average pollutant concentrations across all 7
communities.
For all models, results are presented by contrasting symptoms or lung
function at the 90th percentile of all measurements of a given pollutant to
symptoms or lung function at the 10th percentile of measurements.
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